Hyppää pääsisältöön

ERN-Workshop: Comprehensive gene profiling, m

Lauren 2, Medisiina D, Kiinamyllynkatu 10, Turku, Finland
20500
Turku

Seminaari ja työpaja harvinaisten syöpien molekulaarisesta profiloinnista, tekoälyavusteisesta diagnostiikasta, kohdennetuista hoidoista ja molecular tumor board -toiminnasta

Tilaisuuden ohjelma

Thursday 29th September

Session 1. Artificial intelligence and advances in pathological diagnostics

9:00-9:10 Pia Vihinen, Associate professor, FICAN West Cancer Centre
9:10-9:50 Pekka Ruusuvuori, Prof., Turku Institute of Biomedicine, University of Turku
9:50-10:20 Nina Linder, MD, Associate Prof., Institute for Molecular Medicine Finland and University of Helsinki
10:20-11:00 Tomi Mäkelä, Prof., iCAN – Digital Precision Cancer Medicine Flagship, Helsinki Institute of Life Science, University of Helsinki

11:00-12:00 Lunch

12:00-12:45 Edwin Cuppen, Prof., Hartwig Medical Foundation, Amsterdam, Netherlands

Session 2. Biological basics and novel technics in comprehensive gene profiling

12:45-13:30 Johan Botling, Associate Professor of Pathology, Department of Immunology Genetics and Pathology Rudbeck Laboratory, Uppsala University Hospital, Sweden
13:30-14:00 Merja Perälä, PhD, Associate professor, Auria Biobank and Eva-Maria Talvitie, MD, Turku University
14:00-14:30 Jenni Tuominen, MSc and Katri Orte, MD, PhD, Turku University Hospital and applicants

14:30-15:00 Coffee break

Session 3. Novel technologies in patient sampling and sample analysis

15:30-16:00 Niels Pallisgaard, Prof. Sjællands Universitetshospital, Roskilde, Denmark
15:00-15:30 Juha Kononen, Chief Clinical Director, Docrates Cancer Center, Helsinki
16:00-16:45 2 patient cases presented by applicants (30 min) and discussion
16:45-17:15 Juha Rantala, PhD, Lecturer, Department of Oncology and Metabolism, University of Sheffield, UK
18:00 End of the day 1

Friday 30th September

Session 4. Bringing precision medicine to patients

9:00-9:45 Olli Kallioniemi, Prof., Dept of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
9:45-10:30 Ilse Spiekman, DRUP study coordinator, Netherlands Cancer Institute, Amsterdam Netherlands
10:30-10:50 Erika Alanne, MD, PhD FICAN West Cancer Centre and Turku University Hospital
10:50-11:10 (virtual) Kerry Kingham MS, CGC, Certified Genetic Counselor, Lead, Clinical Assistant Professor of Pediatrics, Cancer Genetics and Genomics, Stanford Cancer Center, USA

11:10-12:00 Lunch

Session 5. Optimal arrangement of Molecular Tumor Boards (MTBs) to support diagnosis of rare cancers and clinical decision-making

12:00-12:30 Kjetil Tasken, Prof., Institute of Clinical Medicine, University of Oslo, Norway
12:30-12:45 Kjetil Tasken, Prof., Institute of Clinical Medicine, University of Oslo, Norway
12:45-13:00 Katriina Peltola, Chief Physician, Clinical Trial Unit, Helsinki Comprehensive Cancer Centre, Helsinki
13:00-13:15 Kristoffer Staal, Head of Phase I Unit, Departmetnt of Oncology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen, Denmark
13:15-13:45 Janne Lehtiö, Prof., Inflames and Karolinska Institutet, Stockholm, Sweden
13:45-14:00 Coffee break

Session 6. MTB and patient cases

14:00-16:00 Virtual Molecular Tumor Board (participants from several institutes) and round table discussion

16:00 Closing remarks and departure

Järjestäjä
FICAN WEST Cancer Centre, Turku University Hospital (TYKS), ERN-EURACAN, ERN-GENTURIS
Yhteyshenkilön nimi
Eva-Maria Talvitie
Yhteyshenkilön sähköposti
eva-maria.talvitie@tyks.fi
Yhteyshenkilön puhelinnumero
+358504112237